Vaccines Investor Event
Sanofi was pleased to host investors and analysts for its Vaccines Investor Event held in person on June 29th, 2023
Featuring
Paul Hudson
Chief Executive Officer
Thomas Triomphe
Head of Vaccines Business Unit
Jean-Francois Toussaint
Head of Vaccines R&D
Kimberly Tutwiler
Head of RSV Franchise
Bill Averbeck
Head of Influenza Franchise
Saranya Sridhar
Head of Translational Medicine
Thomas Grenier
Head of Vaccines Franchise & Product Strategy
Frank DeRosa
Head of Research for mRNA Center of Excellence
Sally Mossman
Head Vaccines Research Portfolio Strategy
Dr William Geisler, MD, MPH
Professor of Medicine & Epidemiology, University of Alabama at Birmingham